Views & Analysis A world leader in genomics, but England’s patients face obst... England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit.
News Health firms should prepare for Amazon move, says J&J chief Johnson & Johnson’s CEO Alex Gorsky says he would welcome the disruptive influence of Amazon should it decide to move into healthcare.
News A Pfizer consumer buyout won't detract from pharma business,... Walmsley has axed 40% of management team in shake-up
News Bad week for dementia R&D after Axovant howler and another f... Axovant misreports trial results, Lundbeck Alzheimer's drug fails
News In shock move, EU panel rejects Alzheimer's drug Leqembi The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh
Sales & Marketing Sponsored How doctors are interacting with content in 10 data trends It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.